KL and breast cancer: Thus, examining Kla as a key link between malignant phenotypes and metabolic abnormalities advances our knowledge of the pathophysiology of BC and offers a theoretical basis for creating targeted therapeutic approaches that target the metabolic-epigenetic-immune microenvironment.